carbazilquinone has been researched along with Dysmyelopoietic Syndromes in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Excerpt | Relevance | Reference |
---|---|---|
"A 77-year-old male, who had been treated with carboquone and busulfan for polycythemia vera (PV), developed myelodysplastic syndrome (MDS) 8 years later." | 3.68 | [Polycythemia vera terminating in myelodysplastic syndrome]. ( Abe, T; Kimura, S; Kobayashi, Y; Kondo, M; Maruo, N; Ozawa, M; Tanaka, R; Uoshima, N; Yoshida, Y, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, S | 1 |
Uoshima, N | 1 |
Tanaka, R | 1 |
Kobayashi, Y | 1 |
Ozawa, M | 1 |
Maruo, N | 1 |
Kondo, M | 1 |
Abe, T | 1 |
Yoshida, Y | 1 |
1 other study available for carbazilquinone and Dysmyelopoietic Syndromes
Article | Year |
---|---|
[Polycythemia vera terminating in myelodysplastic syndrome].
Topics: Aged; Busulfan; Carbazilquinone; Humans; Male; Myelodysplastic Syndromes; Polycythemia Vera | 1990 |